Nanotechnology: emerging tool for diagnostics and therapeutics. Appl Biochem Biotechnol. 2011;165:1178-1187. [PMID: 21847590 DOI: 10.1007/s12010-011-9336-6]

Drug delivery via lipoprotein-based carriers: answering the challenges in systemic therapeutics

Plasma lipoproteins are transporters of lipids and other hydrophobic molecules in the mammalian circulation. Lipoproteins also have a strong potential to serve as drug-delivery vehicles due to their small size, long residence time in the circulation and high-drug payload. Consequently, lipoproteins and synthetic/reconstituted lipoprotein preparations have been evaluated with increasing interest towards clinical applications, particularly for cancer diagnostics/imaging and chemotherapy. In this review, past and current studies on lipoproteins and similar alternative drug carriers are discussed regarding their suitability as agents to deliver drugs, primarily to cancer cells and tumors. A lipoprotein-based delivery strategy may also provide a novel platform for improving the therapeutic efficacy of drugs that have previously been judged unsuitable or had only limited application due to poor solubility. An additional, and perhaps the most important aspect of the drug-delivery process via lipoprotein-type carriers, is the receptor-mediated uptake of the payload from the lipoprotein complex. Monitoring the expression of specific receptors prior to treatment could, thus, give rise to efficient selection of optimally responsive patients, resulting in a successful personalized therapy regimen.

The Separation Power of Nanotubes in Membranes: A Review

Research on mixed matrix membranes in which nanoparticles are used to enhance the membrane's performance in terms of flux, separation, and fouling resistance has boomed in the last years. This review probes on the specific features and benefits of one specific type of nanoparticles with a well-defined cylindrical structure, known as nanotubes. Nanotube structures for potential use in membranes are reviewed. These comprise mainly single-wall carbon nanotubes (SWCNTs) and multiwall carbon nanotubes (MWCNTs), but also other structures and materials, which are less studied for membrane applications, can be used. Important issues related to polymer-nanotube interactions such as dispersion and alignment are outlined, and a categorization is made of the resultant membranes. Applications are reviewed in four different areas, that is, gas separation, water filtration, drug delivery, and fuel cells.

Antibody-targeted nanovectors for the treatment of brain cancers

Introduced here is the hydrophilic carbon clusters (HCCs) antibody drug enhancement system (HADES), a methodology for cell-specific drug delivery. Antigen-targeted, drug-delivering nanovectors are manufactured by combining specific antibodies with drug-loaded poly(ethylene glycol)-HCCs (PEG-HCCs). We show that HADES is highly modular, as both the drug and antibody component can be varied for selective killing of a range of cultured human primary glioblastoma multiforme. Using three different chemotherapeutics and three different antibodies, without the need for covalent bonding to the nanovector, we demonstrate extreme lethality toward glioma, but minimal toxicity toward human astrocytes and neurons.